
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Institute of Clinical Pathology [P. B., H. K., G. B., G. O.] and Department of Gynecology and Obstetrics [A. O., M. S.], University of Vienna, A-1090 Vienna, Austria
Lymphovascular space invasion was shown to play a key role in the progression of cervical cancer. Because of the absence of a specific marker for lymphatic vessels, earlier studies could not reliably distinguish between blood and lymphatic vessel invasion. By immunostaining for podoplanin, a novel marker for lymphatic endothelium, and for factor VIII-related antigen, we determined lymphatic and blood vessel invasion in tissue samples of 98 patients with cervical cancer pT1b treated by radical hysterectomy. Eleven (11.2%) specimens showed invasion of blood vessels, 20 (20.4%) showed invasion of lymphatic vessels, and 15 (15.3%) showed invasion of blood and lymphatic vessels. There was a strong association of lymphatic vessel invasion and lymph node involvement (P < 0.001). In univariate analysis, both blood and lymphatic vessel invasion failed to reach a statistically significant influence on overall survival, but a significant influence on disease-free survival was found (P = 0.0002 and P < 0.0001, respectively). In multivariate analysis of disease-free survival, only blood vessel invasion remained statistically significant (P = 0.0457). Lymphatic vessel invasion reached significance when lymph node status was excluded from the model (P = 0.0025). Both lymphatic vessel and blood vessel invasion occur frequently in early-stage cervical cancer. Determination of the vessel status may be of clinical importance because it signifies the risk of recurrent disease.
This article has been cited by other articles:
![]() |
C. S. Lim, F. Alexander-Sefre, M. Allam, N. Singh, J. C. Aleong, H. Al-Rawi, and I. J. Jacobs Clinical Value of Immunohistochemically Detected Lymphovascular Space Invasion in Early Stage Cervical Carcinoma Ann. Surg. Oncol., September 1, 2008; 15(9): 2581 - 2588. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyata, S. Kanda, K. Ohba, K. Nomata, Y. Hayashida, J. Eguchi, T. Hayashi, and H. Kanetake Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D Clin. Cancer Res., February 1, 2006; 12(3): 800 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Nakamura, H Yasuoka, M Tsujimoto, K Kurozumi, M Nakahara, K Nakao, and K Kakudo Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer J. Clin. Pathol., January 1, 2006; 59(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M Vleugel, R Bos, P van der Groep, A E Greijer, A Shvarts, H V Stel, E van der Wall, and P J van Diest Lack of lymphangiogenesis during breast carcinogenesis J. Clin. Pathol., July 1, 2004; 57(7): 746 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Padera, Y. Boucher, R. K. Jain, L. M. Wein, P. E. Holden, and D. H. Kirn Correspondence re: S. Maula et al., Intratumoral Lymphatics Are Essential for the Metastatic Spread and Prognosis in Squamous Cell Carcinoma of the Head and Neck. Cancer Res., 63: 1920-1926, 2003. Cancer Res., December 1, 2003; 63(23): 8555 - 8557. [Full Text] [PDF] |
||||
![]() |
F Alexander-Sefre, N Singh, A Ayhan, H B Salveson, G Wilbanks, and I J Jacobs Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry J. Clin. Pathol., October 1, 2003; 56(10): 786 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Schoppmann, P. Birner, J. Stockl, R. Kalt, R. Ullrich, C. Caucig, E. Kriehuber, K. Nagy, K. Alitalo, and D. Kerjaschki Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis Am. J. Pathol., September 1, 2002; 161(3): 947 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Jain and T. P. Padera Prevention and Treatment of Lymphatic Metastasis by Antilymphangiogenic Therapy J Natl Cancer Inst, June 5, 2002; 94(11): 785 - 787. [Full Text] [PDF] |
||||
![]() |
M. Schindl, G. Oberhuber, A. Obermair, S. F. Schoppmann, B. Karner, and P. Birner Overexpression of Id-1 Protein Is a Marker for Unfavorable Prognosis in Early-Stage Cervical Cancer Cancer Res., August 1, 2001; 61(15): 5703 - 5706. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Birner, M. Schindl, A. Obermair, G. Breitenecker, and G. Oberhuber Expression of Hypoxia-inducible Factor 1{{alpha}} in Epithelial Ovarian Tumors: Its Impact on Prognosis and on Response to Chemotherapy Clin. Cancer Res., June 1, 2001; 7(6): 1661 - 1668. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |